Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 471
interventional 418
Observational 48
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 140
Drug|placebo 74
Behavioral 41
Dietary Supplement 38
Other 36
Dietary Supplement|placebo 31
Biological|Drug|placebo 8
Procedure 8
Behavioral|Other 6
Biological|placebo 5
Drug|Other 5
Behavioral|Drug 4
Device 4
Behavioral|Device 2
Behavioral|Dietary Supplement|placebo 2
Biological 2
Dietary Supplement|Drug 2
Other|placebo 2
Behavioral|Dietary Supplement|Drug|placebo 1
Behavioral|Drug|placebo 1
Biological|Drug 1
Combination Product|Drug|placebo 1
Device|Other 1
Diagnostic Test|Drug 1
Dietary Supplement|Other 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 132
Korea, Republic of 55
NA 53
Canada 36
China 12
Denmark 10
United Kingdom 10
Netherlands 8
Taiwan 7
United States|Canada 7
France 4
Germany 4
Japan 4
Norway 4
Australia 3
India 3
Iran, Islamic Republic of 3
Mexico 3
Poland 3
Italy 2
Malaysia 2
Singapore 2
Spain 2
Switzerland 2
Turkey 2
United States|Brazil|Canada|Singapore|South Africa|Taiwan|United Kingdom 2
Argentina|Australia|Brazil|Chile|Guatemala|Hong Kong|India|Indonesia|Israel|Jordan|Korea, Republic of|Kuwait|Lebanon|Malaysia|Mexico|Morocco|Pakistan|Peru|Philippines|Saudi Arabia|Singapore|South Africa|Taiwan|Thailand|Tunisia|Turkey|United Arab Emirates| 1
Austria|Belgium|Finland|Greece|Hungary|Ireland|Italy|Portugal|Slovenia|Spain|Switzerland| 1
Belgium|Colombia|Finland|Germany|Israel|Italy|Mexico|Netherlands|Norway|Peru|South Africa|Spain|Sweden 1
Belgium|France|Germany 1
Brazil 1
Bulgaria|Czech Republic|Germany|Slovakia|Ukraine 1
Cameroon 1
Czech Republic|Denmark|France|Germany|Hungary|Netherlands|Poland|Ukraine 1
Egypt 1
Germany|Netherlands 1
Greece 1
Greece|Hungary|Italy|Spain 1
Greece|Israel|Romania|Russian Federation|South Africa 1
Italy|Poland|Portugal|United States|Australia|Belgium|Brazil|Canada|France|Greece|Romania|South Africa|Spain|Switzerland|United Kingdom 1
Lebanon 1
Norway|South Africa 1
Thailand 1
Ukraine|Poland|Italy 1
United States|Argentina|Brazil|Canada|China|Colombia|France|Korea, Republic of|Russian Federation|Turkey 1
United States|Argentina|Italy 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|France|Germany|Hong Kong|Hungary|Italy|Korea, Republic of|Mexico|Netherlands|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark 1
United States|Australia|Belgium|Canada|Denmark|Finland|Spain|Sweden 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Hong Kong|Netherlands|Poland|South Africa|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Korea, Republic of|South Africa|Taiwan|Turkey 1
United States|Australia|Canada|Czech Republic|Germany|Hong Kong|Italy|Korea, Republic of|Poland 1
United States|Australia|Canada|Czechia|Denmark|France|Germany|Italy|Netherlands|New Zealand|Norway|South Africa|United Kingdom 1
United States|Australia|Canada|Denmark|France|Iceland|Norway|South Africa|Sweden| 1
United States|Australia|Canada|France|Germany|Hong Kong|Netherlands|New Zealand|Norway|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
United States|Belgium|Canada|Netherlands|Poland|Spain 1
United States|Belgium|Germany|Korea, Republic of|Mexico|Norway|Sweden|United Kingdom 1
United States|Brazil|Bulgaria|Canada|Denmark|Germany|Hungary|Italy|Mexico|Romania|South Africa 1
United States|Brazil|Canada|France|Germany|Israel|Italy|Netherlands|South Africa|Spain|United Kingdom 1
United States|Canada|Czech Republic|Finland|France|Italy|Netherlands|South Africa 1
United States|Canada|Czechia|Denmark|Hungary 1
United States|Canada|Czechia|Finland|Korea, Republic of|Netherlands|Norway|Poland|Puerto Rico|Singapore|Sweden|United Kingdom 1
United States|Canada|Denmark|Germany|Netherlands 1
United States|Canada|Germany|Netherlands|Poland|United Kingdom 1
United States|Canada|Netherlands 1
United States|China 1
United States|Hungary|Canada|Colombia|France|Lithuania|Mexico|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 309
2 21
3 7
4 7
5 6
6 2
7 3
8 1
10 2
12 1
13 1
14 1
15 3
17 1
18 1
19 3
20 3
25 1
26 1
28 1
30 1
32 1
33 2
35 1
36 1
39 1
40 1
41 2
42 1
43 1
44 2
46 1
49 1
54 1
57 1
58 3
59 1
67 2
68 1
75 1
78 2
83 1
100 1
102 1
103 1
104 1
107 1
110 2
118 1
147 1
154 1
223 1
244 1
249 1
363 1

Phase

Phase Study_Count
N/A 151
Phase 3 93
Phase 2 51
Phase 1 48
Phase 4 48
Phase 2/Phase 3 16
Phase 1/Phase 2 9
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 35
2 170
3 71
4 44
5 8
6 14
8 3
9 2
24 1
NA 70

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 30 6.0000 6.0 8.0000 2.0000 9.0 18.0000 11.0000
1st Qu. 41 29.5000 24.0 39.0000 36.0000 19.5 146.0000 40.0000
Median 52 57.0000 42.0 52.0000 116.0000 56.5 307.0000 74.0000
Mean 52 462.8311 48.5 116.5556 153.3191 66.5 584.8387 380.0833
3rd Qu. 63 156.2500 60.0 108.0000 225.0000 80.0 646.0000 310.7500
Max. 74 24000.0000 200.0 561.0000 631.0000 211.0 3800.0000 8000.0000

Trial Group Type

group_type Group_Count
Experimental 480
Active Comparator 229
Placebo Comparator 152
NA 70
Other 47
No Intervention 44
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 248
Crossover Assignment 102
Single Group Assignment 51
Factorial Assignment 9
NA 8

Primary Purpose

primary_purpose Study_Count
Treatment 258
Prevention 68
Basic Science 37
Health Services Research 13
Supportive Care 13
NA 11
Other 7
Diagnostic 6
Screening 3
Educational/Counseling/Training 2

Observational Studies

Studies by Country

Country Study_Count
United States 13
NA 10
Austria 3
Germany 3
Denmark 2
Greece 2
Japan 2
Taiwan 2
Austria|Belgium|France|Germany|Greece|Norway|Russian Federation|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Belgium|Austria|Bulgaria|Czechia|Germany|Greece|Italy|Portugal|Slovakia|Spain|Sweden|Switzerland 1
Brazil 1
Canada 1
China 1
Italy 1
Korea, Republic of 1
Mexico 1
Netherlands 1
Sweden 1
Thailand 1

Sites per Study

Site_count Study_Count
1 36
2 4
7 1
8 1
11 1
12 1
15 1
17 1
190 1
778 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 109.500
Median 482.000
Mean 1337.761
3rd Qu 1072.000
Max 15330.000

Observation Model

observational_model Study_Count
Cohort 23
NA 7
Other 6
Case-Only 3
Case Control 3
Family-Based 2
Case-Control 1
Case Control, Natural History 1
Defined Population 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 32
NA 6
Cross-Sectional 5
Retrospective 3
Cross-Sectional, Prospective 2

Registries

Studies by Country

Country Study_Count
China 2
Germany 1
Poland 1
United States 1

Sites per Study

Site_count Study_Count
1 4
14 1

Enrollment Metrics

Measure Registries
Min 16.0
1st Qu 108.0
Median 7658.0
Mean 10756.4
3rd Qu 21000.0
Max 25000.0

Registry Model

observational_model Study_Count
Cohort 3
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 3
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
1 Day 1
1 Year 1
15 Years 1
3 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03370848 Effects of Psyllium on Niacin Tolerability https://ClinicalTrials.gov/show/NCT03370848 Completed VA Greater Los Angeles Healthcare System 2011-07-31
NCT03360747 Phase 2 Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Familial Chylomicronemia Syndrome (FCS) https://ClinicalTrials.gov/show/NCT03360747 Completed Akcea Therapeutics 2018-09-04
NCT03344692 Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03344692 Recruiting Nantes University Hospital 2021-12-31
NCT03337308 A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy https://ClinicalTrials.gov/show/NCT03337308 Completed Esperion Therapeutics 2018-06-18
NCT03330548 Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors https://ClinicalTrials.gov/show/NCT03330548 Recruiting Phoenix VA Health Care System 2021-05-31
NCT03284918 Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester https://ClinicalTrials.gov/show/NCT03284918 Completed Raisio Group 2016-03-31
NCT03213288 Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status https://ClinicalTrials.gov/show/NCT03213288 Completed Quadram Institute Bioscience 2018-09-30
NCT03173495 Effects of Exercise on Fructose-induced Postprandial Lipemia https://ClinicalTrials.gov/show/NCT03173495 Completed Federal University of Rio Grande do Sul 2016-12-15
NCT03154216 Milk as a Recovery Beverage After Exercise for Improving Metabolic Health https://ClinicalTrials.gov/show/NCT03154216 Completed University of Saskatchewan 2018-12-01
NCT03141827 The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production https://ClinicalTrials.gov/show/NCT03141827 Completed University Health Network, Toronto 2017-02-15
NCT03116516 Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin https://ClinicalTrials.gov/show/NCT03116516 Completed Yuhan Corporation 2017-05-26
NCT03103256 Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 https://ClinicalTrials.gov/show/NCT03103256 Completed Yuhan Corporation 2018-04-30
NCT03079648 Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride https://ClinicalTrials.gov/show/NCT03079648 Completed Chonbuk National University Hospital 2018-04-06
NCT03070782 Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease https://ClinicalTrials.gov/show/NCT03070782 Completed Akcea Therapeutics 2018-07-18
NCT03067688 Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT03067688 Completed Yuhan Corporation 2018-03-27
NCT03017950 Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 https://ClinicalTrials.gov/show/NCT03017950 Completed Chong Kun Dang Pharmaceutical 2017-03-31
NCT03009474 Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers https://ClinicalTrials.gov/show/NCT03009474 Completed CJ HealthCare Corporation 2015-04-30
NCT02995720 A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin https://ClinicalTrials.gov/show/NCT02995720 Completed Boryung Pharmaceutical Co., Ltd 2016-11-10
NCT02994745 A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers. https://ClinicalTrials.gov/show/NCT02994745 Completed Boryung Pharmaceutical Co., Ltd 2017-02-21
NCT02992301 Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab https://ClinicalTrials.gov/show/NCT02992301 Active, not recruiting Westside Medical Associates of Los Angeles 2019-11-30
NCT02991534 Cardiovascular Risk Screening and Risk Reduction in Women Vets https://ClinicalTrials.gov/show/NCT02991534 Recruiting VA Office of Research and Development 2020-08-31
NCT02991118 Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk https://ClinicalTrials.gov/show/NCT02991118 Completed Esperion Therapeutics 2018-08-22
NCT02988115 Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant https://ClinicalTrials.gov/show/NCT02988115 Completed Esperion Therapeutics 2018-03-16
NCT02982798 The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02982798 Completed Jeil Pharmaceutical Co., Ltd. 2017-08-30
NCT02959762 Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K ‘n’ Kids Study II) https://ClinicalTrials.gov/show/NCT02959762 Active, not recruiting Augusta University 2020-12-01
NCT02951962 A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin https://ClinicalTrials.gov/show/NCT02951962 Completed Yuhan Corporation 2016-09-30
NCT02942602 Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT02942602 Completed Yonsei University 2016-05-23
NCT02941796 Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02941796 Completed Hanmi Pharmaceutical Company Limited 2016-07-31
NCT02927184 Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02927184 Completed Viking Therapeutics, Inc. 2019-03-26
NCT02924896 Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation https://ClinicalTrials.gov/show/NCT02924896 Completed Imperial College London 2017-04-30
NCT02907112 Impact of Reducing Dietary Intake of Red and Processed Meat Intake on Fasting Lipemia in Healthy Participants https://ClinicalTrials.gov/show/NCT02907112 Completed University of Nottingham 2016-09-30
NCT02905448 Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases https://ClinicalTrials.gov/show/NCT02905448 Completed Barbara Jakše s.p. 2017-03-31
NCT02899455 Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia https://ClinicalTrials.gov/show/NCT02899455 Completed Hanmi Pharmaceutical Company Limited 2016-06-30
NCT02842359 Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension https://ClinicalTrials.gov/show/NCT02842359 Completed Sanofi 2018-04-19
NCT02839902 Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood https://ClinicalTrials.gov/show/NCT02839902 Completed Takeda 2017-08-30
NCT02839382 The Northwest Coalition for Primary Care Practice Support https://ClinicalTrials.gov/show/NCT02839382 Completed Kaiser Permanente 2018-05-01
NCT02824432 Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation https://ClinicalTrials.gov/show/NCT02824432 Completed Takeda 2017-08-19
NCT02767531 Orlistat for the Treatment of Type I Hyperlipoproteinemia https://ClinicalTrials.gov/show/NCT02767531 Active, not recruiting University of Texas Southwestern Medical Center 2018-05-31
NCT02742545 Impact of MayoExpertAdvisor on Provider Adherence https://ClinicalTrials.gov/show/NCT02742545 Completed Mayo Clinic 2016-11-30
NCT02729025 Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) https://ClinicalTrials.gov/show/NCT02729025 Completed Amgen 2018-04-05
NCT02719028 Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia https://ClinicalTrials.gov/show/NCT02719028 Completed Golden Biotechnology Corporation 2018-09-27
NCT02697422 Veteran Peer Coaches Optimizing and Advancing Cardiac Health https://ClinicalTrials.gov/show/NCT02697422 Recruiting VA Office of Research and Development 2020-08-31
NCT02676596 Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects https://ClinicalTrials.gov/show/NCT02676596 Completed Kowa Research Institute, Inc. 2014-11-30
NCT02668016 Self-Assessment Method for Statin Side-effects Or Nocebo https://ClinicalTrials.gov/show/NCT02668016 Active, not recruiting Imperial College London 2020-02-29
NCT02666664 Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony) https://ClinicalTrials.gov/show/NCT02666664 Completed Esperion Therapeutics 2018-02-21
NCT02662569 Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02662569 Completed Amgen 2017-12-06
NCT02659397 A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg https://ClinicalTrials.gov/show/NCT02659397 Completed Esperion Therapeutics 2016-07-31
NCT02658175 The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome https://ClinicalTrials.gov/show/NCT02658175 Active, not recruiting Ionis Pharmaceuticals, Inc. 2020-06-30
NCT02634034 A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT02634034 Completed Kowa Research Institute, Inc. 2015-12-31
NCT02628990 Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks https://ClinicalTrials.gov/show/NCT02628990 Completed Raisio Group 2005-08-31
NCT02623790 Study of the Impact of Cheese Matrix on Postprandial Lipemia: a Clinical Study https://ClinicalTrials.gov/show/NCT02623790 Completed Laval University 2016-06-30
NCT02593032 Effects of Use of a Connected Pillbox On Medication Adherence https://ClinicalTrials.gov/show/NCT02593032 Completed University of Pennsylvania 2017-04-30
NCT02582424 Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. https://ClinicalTrials.gov/show/NCT02582424 Completed Primus Pharmaceuticals 2013-08-31
NCT02569814 A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin https://ClinicalTrials.gov/show/NCT02569814 Completed Boryung Pharmaceutical Co., Ltd 2015-12-31
NCT02566187 A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet https://ClinicalTrials.gov/show/NCT02566187 Completed Boryung Pharmaceutical Co., Ltd 2015-10-31
NCT02512276 Tele-Pharmacy Intervention to Improve Treatment Adherence https://ClinicalTrials.gov/show/NCT02512276 Completed Brigham and Women’s Hospital 2017-08-31
NCT02511418 Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure https://ClinicalTrials.gov/show/NCT02511418 Completed Mayo Clinic 2007-01-31
NCT02506920 Gender Dependent Difference in Lipemia After 6 x OFTT in Young Healthy Subjects https://ClinicalTrials.gov/show/NCT02506920 Completed Herning Hospital 1997-04-30
NCT02505854 Influence of Probiotic and Symbiotic in Body Weight, Blood Sugar and Lipemia of Obese Women https://ClinicalTrials.gov/show/NCT02505854 Completed Universidade Federal do Rio de Janeiro 2016-12-31
NCT02458287 Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia https://ClinicalTrials.gov/show/NCT02458287 Completed Pfizer 2016-02-29
NCT02451098 Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 https://ClinicalTrials.gov/show/NCT02451098 Completed Chong Kun Dang Pharmaceutical 2015-10-31
NCT02449187 Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02449187 Completed Jeil Pharmaceutical Co., Ltd. 2017-09-15
NCT02437084 Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling https://ClinicalTrials.gov/show/NCT02437084 Completed Stanford University 2020-02-29
NCT02433288 Rosuvastatin Adherence App Study in China https://ClinicalTrials.gov/show/NCT02433288 Completed AstraZeneca 2016-10-28
NCT02428998 Safety for 24 Weeks Intake of Korean Red Ginseng in Adults https://ClinicalTrials.gov/show/NCT02428998 Completed Korea Ginseng Corporation 2016-08-31
NCT02418637 Pilot Study Testing Feasibility of Health Screening at Farm Site https://ClinicalTrials.gov/show/NCT02418637 Completed Mayo Clinic 2016-09-30
NCT02387619 The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine https://ClinicalTrials.gov/show/NCT02387619 Completed Jeil Pharmaceutical Co., Ltd. 2015-03-31
NCT02366156 A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism https://ClinicalTrials.gov/show/NCT02366156 Completed Access Business Group 2015-03-31
NCT02365987 The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety https://ClinicalTrials.gov/show/NCT02365987 Completed King’s College London 2015-06-30
NCT02343471 The Effect of Whey Protein Consumed as a Pre-meal on Postprandial Lipemia in Healthy and Subjects With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT02343471 Completed Aarhus University Hospital 2015-04-30
NCT02331043 Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester https://ClinicalTrials.gov/show/NCT02331043 Completed Raisio Group 2013-08-31
NCT02316808 Cholesterol-lowering Effects of Plant Stanol Ester https://ClinicalTrials.gov/show/NCT02316808 Completed Raisio Group 2011-12-31
NCT02295293 The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT02295293 Completed Shiraz University of Medical Sciences 2015-04-30
NCT02280590 Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT02280590 Completed Dong-A ST Co., Ltd. 2015-06-30
NCT02275156 Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab https://ClinicalTrials.gov/show/NCT02275156 Completed Amgen 2014-12-19
NCT02262832 Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy https://ClinicalTrials.gov/show/NCT02262832 Recruiting National Institutes of Health Clinical Center (CC) 2025-07-31
NCT02262806 Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy https://ClinicalTrials.gov/show/NCT02262806 Recruiting National Institutes of Health Clinical Center (CC) 2025-07-31
NCT02259153 Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis https://ClinicalTrials.gov/show/NCT02259153 Completed Instituto Aragones de Ciencias de la Salud 2014-05-31
NCT02228252 The Effect of Protein Quality and Time-factor by Consumption of a Pre-meal on Postprandial Lipemia in Subjects With the Metabolic Syndrome. https://ClinicalTrials.gov/show/NCT02228252 Completed Aarhus University Hospital 2015-03-31
NCT02221297 Lipid-lowering Effect of a Plant Stanol Ester Supplement Product https://ClinicalTrials.gov/show/NCT02221297 Completed Raisio Group 2014-11-30
NCT02215408 MEDication Focused Outpatient Care for Underutilization of Secondary Prevention https://ClinicalTrials.gov/show/NCT02215408 Completed University of Iowa 2017-06-30
NCT02189837 Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody https://ClinicalTrials.gov/show/NCT02189837 Completed Amgen 2015-02-13
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels https://ClinicalTrials.gov/show/NCT02187757 Completed PreEmptive Meds, Pvt. Ltd 2014-11-30
NCT02186483 Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin https://ClinicalTrials.gov/show/NCT02186483 Completed Jeil Pharmaceutical Co., Ltd. 2015-02-28
NCT04066400 Role of a Wheat Containing Diet on Non-alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT04066400 Recruiting Johannes Gutenberg University Mainz 2020-09-01
NCT02135029 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins https://ClinicalTrials.gov/show/NCT02135029 Completed Pfizer 2015-11-30
NCT02130505 Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes https://ClinicalTrials.gov/show/NCT02130505 Completed Sint Franciscus Gasthuis 2008-06-30
NCT02127177 Long-term Effects of CPAP on Lipidemia and Hs-CRP Levels in OSA Patients https://ClinicalTrials.gov/show/NCT02127177 Completed Chinese Pulmonary Vascular Disease Research Group 2013-12-31
NCT02116517 Effects of Green Tea Extract on Obese Women With High Level of LDL https://ClinicalTrials.gov/show/NCT02116517 Completed National Yang Ming University 2013-10-31
NCT02100514 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events https://ClinicalTrials.gov/show/NCT02100514 Completed Pfizer 2016-07-15
NCT02098278 Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia https://ClinicalTrials.gov/show/NCT02098278 Completed Catabasis Pharmaceuticals 2015-04-30
NCT02087124 Dose-response Effect of Whey Protein Consumed as Pre-meal on Postprandial Lipaemia in Subjects With Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02087124 Completed Aarhus University Hospital 2014-06-30
NCT02064881 Efficacy Study of Metformin Glycinate on Postprandial Lipemia https://ClinicalTrials.gov/show/NCT02064881 Recruiting Laboratorios Silanes S.A. de C.V. 2020-04-30
NCT01317524 The Effects of Homogenized and Unhomogenized Milk on Postprandial Metabolism in Healthy Overweight Men https://ClinicalTrials.gov/show/NCT01317524 Completed Maastricht University Medical Center 2011-06-30
NCT01308710 The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia https://ClinicalTrials.gov/show/NCT01308710 Completed University of California, San Francisco 2011-07-31
NCT01291641 Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease https://ClinicalTrials.gov/show/NCT01291641 Completed Seoul National University Hospital 2016-12-31
NCT01279590 Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) https://ClinicalTrials.gov/show/NCT01279590 Completed Furiex Pharmaceuticals, Inc 2011-11-30
NCT01280604 Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy https://ClinicalTrials.gov/show/NCT01280604 Completed Kaiser Permanente 2013-01-31
NCT02056847 to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia https://ClinicalTrials.gov/show/NCT02056847 Completed JW Pharmaceutical 2017-05-31
NCT02047175 CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) https://ClinicalTrials.gov/show/NCT02047175 Completed Chong Kun Dang Pharmaceutical 2014-03-31
NCT02044627 Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 https://ClinicalTrials.gov/show/NCT02044627 Completed Esperion Therapeutics 2014-01-31
NCT02029989 Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness https://ClinicalTrials.gov/show/NCT02029989 Completed University of Minnesota 2012-02-29
NCT02012855 Effect of Different Types of Carbohydrates Consumed After Exercise on Blood Fat Levels https://ClinicalTrials.gov/show/NCT02012855 Completed University of Saskatchewan 2015-08-31
NCT02008084 A Pilot Study to Evaluate the Lipid Effects of TRIA-662 https://ClinicalTrials.gov/show/NCT02008084 Completed Cortria Corporation 2015-10-31
NCT01968967 Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events https://ClinicalTrials.gov/show/NCT01968967 Completed Pfizer 2016-07-05
NCT01968954 Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events https://ClinicalTrials.gov/show/NCT01968954 Completed Pfizer 2016-04-30
NCT01968720 Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT01968720 Completed Catabasis Pharmaceuticals 2014-04-30
NCT01953328 Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk https://ClinicalTrials.gov/show/NCT01953328 Completed Amgen 2014-06-30
NCT01918709 Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT01918709 Completed LG Life Sciences 2011-11-30
NCT01918358 Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg https://ClinicalTrials.gov/show/NCT01918358 Completed LG Life Sciences 2013-01-31
NCT01918332 Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01918332 Completed LG Life Sciences 2013-03-31
NCT01914432 Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01914432 Completed Yuhan Corporation 2014-06-30
NCT01912560 Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01912560 Completed Catabasis Pharmaceuticals 2013-12-31
NCT01911390 Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children https://ClinicalTrials.gov/show/NCT01911390 Completed Poudre Valley Health System 2016-10-31
NCT01890226 A Mobile Personal Health Record for Behavioral Health Homes https://ClinicalTrials.gov/show/NCT01890226 Completed Emory University 2018-11-30
NCT01886326 Eating Peanuts for Health https://ClinicalTrials.gov/show/NCT01886326 Completed Purdue University 2012-05-31
NCT01884246 Improving Heart Health in Appalachia https://ClinicalTrials.gov/show/NCT01884246 Completed University of Kentucky 2016-12-31
NCT01882517 Lipid-lowering Effect of Plant Stanol Yogurt https://ClinicalTrials.gov/show/NCT01882517 Completed Raisio Group 2012-01-31
NCT01878227 Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01878227 Completed Zhejiang University 2011-05-31
NCT01865370 Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects https://ClinicalTrials.gov/show/NCT01865370 Completed Chonbuk National University Hospital 2012-02-29
NCT01864239 The Medicines Advice Service Evaluation https://ClinicalTrials.gov/show/NCT01864239 Completed University College, London 2014-09-30
NCT01858376 Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans https://ClinicalTrials.gov/show/NCT01858376 Completed Ohio State University 2015-01-31
NCT01854918 Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01854918 Completed Amgen 2018-05-31
NCT01845428 Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome https://ClinicalTrials.gov/show/NCT01845428 Completed University of North Carolina, Chapel Hill 2017-01-31
NCT01842256 Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. https://ClinicalTrials.gov/show/NCT01842256 Completed Chong Kun Dang Pharmaceutical 2013-05-31
NCT01842230 Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine https://ClinicalTrials.gov/show/NCT01842230 Completed Chong Kun Dang Pharmaceutical 2013-05-31
NCT01811082 Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01811082 Completed Zhejiang University 2011-05-31
NCT01806324 A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01806324 Completed HanAll BioPharma Co., Ltd. 2012-11-30
NCT01764178 Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects https://ClinicalTrials.gov/show/NCT01764178 Completed JW Pharmaceutical 2013-03-15
NCT01763918 Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 https://ClinicalTrials.gov/show/NCT01763918 Completed Amgen 2013-11-27
NCT01763905 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 https://ClinicalTrials.gov/show/NCT01763905 Completed Amgen 2013-11-19
NCT01763866 LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 https://ClinicalTrials.gov/show/NCT01763866 Completed Amgen 2013-11-12
NCT01763827 Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 https://ClinicalTrials.gov/show/NCT01763827 Completed Amgen 2013-10-10
NCT01761955 Metabolic Health Benefits of Dairy Protein https://ClinicalTrials.gov/show/NCT01761955 Completed University of Manitoba 2011-05-31
NCT01739153 Effect of Cheese on Cardiovascular Risk https://ClinicalTrials.gov/show/NCT01739153 Completed University of Copenhagen 2013-08-31
NCT01725815 The Health Access and Recovery Peer Program https://ClinicalTrials.gov/show/NCT01725815 Completed Emory University 2016-06-01
NCT01708681 Lean Seafood Intake and Postprandial Metabolism https://ClinicalTrials.gov/show/NCT01708681 Completed National Institute of Nutrition and Seafood Research, Norway 2013-05-31
NCT01694446 Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose https://ClinicalTrials.gov/show/NCT01694446 Completed University Health Network, Toronto 2013-01-31
NCT01680211 Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients https://ClinicalTrials.gov/show/NCT01680211 Completed Olive Lifesciences Pvt Ltd 2012-06-30
NCT01678183 Financial Incentives for Medication Adherence https://ClinicalTrials.gov/show/NCT01678183 Completed Boston Medical Center 2014-04-30
NCT01675154 Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia https://ClinicalTrials.gov/show/NCT01675154 Active, not recruiting University of Texas Southwestern Medical Center 2020-07-31
NCT01671254 Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation https://ClinicalTrials.gov/show/NCT01671254 Completed MetaProteomics LLC 2012-12-31
NCT01647438 Translating a Heart Disease Lifestyle Intervention Into the Community https://ClinicalTrials.gov/show/NCT01647438 Completed Northwestern University 2013-12-31
NCT01644942 Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation https://ClinicalTrials.gov/show/NCT01644942 Completed University Hospital, Montpellier 2013-06-30
NCT01642355 Prevention Trial to Achieve Cardiovascular Targets https://ClinicalTrials.gov/show/NCT01642355 Completed NYU Langone Health 2016-05-31
NCT01634906 Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy https://ClinicalTrials.gov/show/NCT01634906 Completed Sint Franciscus Gasthuis 2013-03-31
NCT01618071 Vascular Effects of Triglyceride-rich Lipoproteins https://ClinicalTrials.gov/show/NCT01618071 Completed King’s College London 2012-10-31
NCT01609907 Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan https://ClinicalTrials.gov/show/NCT01609907 Completed Yuhan Corporation 2012-05-31
NCT01607294 A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT01607294 Completed Esperion Therapeutics 2012-10-31
NCT01606930 A Pilot Study to Improve Patient-Doctor Communication https://ClinicalTrials.gov/show/NCT01606930 Completed Walter Reed National Military Medical Center 2011-11-30
NCT01600703 Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans https://ClinicalTrials.gov/show/NCT01600703 Completed University Health Network, Toronto 2013-05-31
NCT01597843 Veterans Service Organizations and My HealtheVet (MHV) https://ClinicalTrials.gov/show/NCT01597843 Completed VA Office of Research and Development 2013-06-30
NCT01586897 The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care https://ClinicalTrials.gov/show/NCT01586897 Completed Massachusetts General Hospital 2013-05-31
NCT01571609 Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders https://ClinicalTrials.gov/show/NCT01571609 Completed University of Aarhus 2013-07-31
NCT01562080 Combined Effects of Bioactive Compounds in Lipid Profile https://ClinicalTrials.gov/show/NCT01562080 Completed Rottapharm Spain 2012-06-30
NCT01550432 Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation https://ClinicalTrials.gov/show/NCT01550432 Completed Stanford University 2012-07-31
NCT01541943 Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01541943 Completed HanAll BioPharma Co., Ltd. 2014-11-30
NCT01524289 Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) https://ClinicalTrials.gov/show/NCT01524289 Completed Merck Sharp & Dohme Corp. 2014-02-12
NCT01476436 Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers https://ClinicalTrials.gov/show/NCT01476436 Completed Oslo University Hospital 2017-09-22
NCT01448174 Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT01448174 Completed Poznan University of Medical Sciences 2014-10-31
NCT01442987 Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia https://ClinicalTrials.gov/show/NCT01442987 Completed Hanmi Pharmaceutical Company Limited 2013-04-30
NCT01435382 A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT01435382 Completed Pfizer 2012-02-29
NCT01426412 A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol https://ClinicalTrials.gov/show/NCT01426412 Completed Eli Lilly and Company 2013-06-30
NCT01420016 Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk https://ClinicalTrials.gov/show/NCT01420016 Completed HealthPartners Institute 2014-08-19
NCT01414803 Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia https://ClinicalTrials.gov/show/NCT01414803 Completed Yonsei University 2011-04-30
NCT01409434 Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study https://ClinicalTrials.gov/show/NCT01409434 Completed University of Florida 2013-08-31
NCT01406431 Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects https://ClinicalTrials.gov/show/NCT01406431 Completed JW Pharmaceutical 2011-08-31
NCT01402128 Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects https://ClinicalTrials.gov/show/NCT01402128 Completed Chonbuk National University Hospital 2010-10-31
NCT01402102 A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01402102 Completed Chonbuk National University Hospital 2011-03-31
NCT01391585 Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management https://ClinicalTrials.gov/show/NCT01391585 Completed Denver Health and Hospital Authority 2012-08-31
NCT01388816 A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels https://ClinicalTrials.gov/show/NCT01388816 Completed Dr. Reddy’s Laboratories Limited 2012-05-31
NCT01380730 LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy https://ClinicalTrials.gov/show/NCT01380730 Completed Amgen 2012-04-05
NCT01377064 Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk https://ClinicalTrials.gov/show/NCT01377064 Completed University of South Carolina 2013-07-31
NCT01375777 Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels https://ClinicalTrials.gov/show/NCT01375777 Completed Amgen 2012-03-02
NCT01375764 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects https://ClinicalTrials.gov/show/NCT01375764 Completed Amgen 2012-05-08
NCT01360567 The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01360567 Completed Taipei City Hospital 2012-11-30
NCT01353404 Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) https://ClinicalTrials.gov/show/NCT01353404 Completed Samyang Biopharmaceuticals Corporation 2011-08-31
NCT01349010 Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia https://ClinicalTrials.gov/show/NCT01349010 Completed Otsuka Beijing Research Institute 2012-07-31
NCT01332747 Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation https://ClinicalTrials.gov/show/NCT01332747 Completed Jamia Hamdard University 2011-05-31
NCT01327014 Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01327014 Completed Beijing Peking University WBL Biotech Co., Ltd. 2012-12-31
NCT01326442 Vitamin D and Omega-3 Inhibit Metabolic Syndrome https://ClinicalTrials.gov/show/NCT01326442 Completed University of Guelph 2012-12-31
NCT04438096 Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia https://ClinicalTrials.gov/show/NCT04438096 Recruiting CVI Pharmaceuticals 2021-12-15
NCT04419948 Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM https://ClinicalTrials.gov/show/NCT04419948 Recruiting Harokopio University 2020-12-31
NCT04354987 Compare the Pharmacokinetics and Safety of CKD-391 https://ClinicalTrials.gov/show/NCT04354987 Completed Chong Kun Dang Pharmaceutical 2020-01-09
NCT04346836 Low-intensity Exercise in Metabolic Syndrome https://ClinicalTrials.gov/show/NCT04346836 Completed University School of Physical Education in Wroclaw 2019-05-10
NCT04245319 Combined Effect of Acitretin and nbUVB on Vitiligo Repigmentation https://ClinicalTrials.gov/show/NCT04245319 Recruiting Cairo University 2020-05-30
NCT04209244 Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT04209244 Recruiting Rigshospitalet, Denmark 2023-07-31
NCT04201314 Effect of InnoSlim® on Blood Sugar and Blood Lipids Regulation in Humans https://ClinicalTrials.gov/show/NCT04201314 Enrolling by invitation Chung Shan Medical University 2020-07-31
NCT04164446 Supplementation of Oil Palm Phenolics to Healthy Participants https://ClinicalTrials.gov/show/NCT04164446 Recruiting National University of Malaysia 2020-04-30
NCT04118348 Evaluating the Efficacy of Pediatric Lipid Screening Alerts https://ClinicalTrials.gov/show/NCT04118348 Enrolling by invitation Geisinger Clinic 2020-10-31
NCT04073134 The CHORAL Flow Study https://ClinicalTrials.gov/show/NCT04073134 Recruiting Imperial College London 2022-03-27
NCT04069715 The Effect of Farlong® NotoGinsengâ„¢ (Farlong® Ginseng Plu®) on Cholesterol and Blood Pressure https://ClinicalTrials.gov/show/NCT04069715 Enrolling by invitation LongStar HealthPro, Inc. DBA Farlong Pharmaceutical 2020-02-28
NCT04063137 Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals https://ClinicalTrials.gov/show/NCT04063137 Active, not recruiting National University, Singapore 2020-12-30
NCT04036773 Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI) https://ClinicalTrials.gov/show/NCT04036773 Recruiting Oregon Health and Science University 2020-07-15
NCT03973931 Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications https://ClinicalTrials.gov/show/NCT03973931 Recruiting University of Colorado, Denver 2023-06-30
NCT03966846 Kefir and Metabolic Syndrome https://ClinicalTrials.gov/show/NCT03966846 Completed Izmir Katip Celebi University 2017-07-31
NCT03964857 Blended Oil Beneficial for Blood Lipids Management https://ClinicalTrials.gov/show/NCT03964857 Active, not recruiting Clinical Nutrition Research Centre, Singapore 2021-02-28
NCT03958734 Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1 https://ClinicalTrials.gov/show/NCT03958734 Active, not recruiting Virginia Commonwealth University 2020-08-31
NCT03944109 The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03944109 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2020-06-30
NCT03860688 Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins https://ClinicalTrials.gov/show/NCT03860688 Recruiting University Health Network, Toronto 2020-12-31
NCT03857256 Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia. https://ClinicalTrials.gov/show/NCT03857256 Recruiting Montreal Heart Institute 2020-11-01
NCT03847506 Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets https://ClinicalTrials.gov/show/NCT03847506 Recruiting CJ HealthCare Corporation 2019-11-05
NCT03828188 Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level https://ClinicalTrials.gov/show/NCT03828188 Completed Chonbuk National University Hospital 2018-05-11
NCT03793985 Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 https://ClinicalTrials.gov/show/NCT03793985 Completed Chong Kun Dang Pharmaceutical 2018-10-23
NCT03741621 Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals https://ClinicalTrials.gov/show/NCT03741621 Completed St. Michael’s Hospital, Toronto 1994-01-31
NCT03718286 Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI https://ClinicalTrials.gov/show/NCT03718286 Recruiting Population Health Research Institute 2020-07-31
NCT03708887 The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients https://ClinicalTrials.gov/show/NCT03708887 Recruiting Zhejiang University 2020-03-01
NCT03689946 Effect of Evolocumab on Coronary Artery Plaque Volume and Composition by CCTA and Microcalcification by F18-NaF PET https://ClinicalTrials.gov/show/NCT03689946 Recruiting Cedars-Sinai Medical Center 2021-12-31
NCT03689803 the Related Factors of Bariatric Surgery on Lipidemia https://ClinicalTrials.gov/show/NCT03689803 Active, not recruiting First Affiliated Hospital of Jinan University 2018-12-31
NCT03680027 Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects https://ClinicalTrials.gov/show/NCT03680027 Completed Eastern Mediterranean University 2015-08-27
NCT03657472 Bioequivalence Study of CJ-30061 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT03657472 Completed CJ HealthCare Corporation 2016-10-29
NCT03656367 Designing Biofunctional Dairy Foods: Matrix Structure of Dairy Products in Relation to Lipaemia https://ClinicalTrials.gov/show/NCT03656367 Completed University of Copenhagen 2019-03-21
NCT03643705 A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention https://ClinicalTrials.gov/show/NCT03643705 Recruiting Case Western Reserve University 2022-06-30
NCT03643094 Golden Black Seed: Support of Metabolic Health and General Wellness. https://ClinicalTrials.gov/show/NCT03643094 Completed Natural Immune Systems Inc 2018-08-14
NCT03639480 Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03639480 Enrolling by invitation CJ HealthCare Corporation 2018-10-31
NCT03632668 Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072 https://ClinicalTrials.gov/show/NCT03632668 Completed Addpharma Inc. 2019-01-24
NCT03607383 Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study https://ClinicalTrials.gov/show/NCT03607383 Recruiting Saint-Joseph University 2020-04-30
NCT03592355 Virtual Visits at Brigham and Women’s Hospital https://ClinicalTrials.gov/show/NCT03592355 Enrolling by invitation Brigham and Women’s Hospital 2020-07-01
NCT03586037 Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012 https://ClinicalTrials.gov/show/NCT03586037 Completed Addpharma Inc. 2018-08-09
NCT03566316 Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03566316 Completed IlDong Pharmaceutical Co Ltd 2017-06-16
NCT03550287 Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia https://ClinicalTrials.gov/show/NCT03550287 Completed Instituto de Investigación Hospital Universitario La Paz 2017-06-30
NCT03536598 Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT03536598 Completed CJ HealthCare Corporation 2017-09-04
NCT03534661 L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release https://ClinicalTrials.gov/show/NCT03534661 Completed University Health Network, Toronto 2019-03-20
NCT03523403 Obesity-related Health Benefits of Apples https://ClinicalTrials.gov/show/NCT03523403 Completed University of Guelph 2018-12-19
NCT03515590 Emulsion Droplet Physical State on Postprandial Lipemia and Satiety https://ClinicalTrials.gov/show/NCT03515590 Recruiting University of Guelph 2019-12-31
NCT03464240 Glucose-stimulated Gut Lipid Release https://ClinicalTrials.gov/show/NCT03464240 Completed University Health Network, Toronto 2017-08-11
NCT03461081 Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT03461081 Completed Jeil Pharmaceutical Co., Ltd. 2017-07-12
NCT03442972 Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids https://ClinicalTrials.gov/show/NCT03442972 Recruiting University Health Network, Toronto 2019-08-01
NCT03439878 Effect of Galactose Ingestion on Postprandial Lipemia https://ClinicalTrials.gov/show/NCT03439878 Completed University of Bath 2018-05-01
NCT03435432 Plasma Lipid Response to Glucose Drink https://ClinicalTrials.gov/show/NCT03435432 Completed University Health Network, Toronto 2016-06-16
NCT03434613 A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03434613 Completed Yonsei University 2019-09-11
NCT03422666 Plasma Lipoprotein Response to Glucagon-like Peptide-2 https://ClinicalTrials.gov/show/NCT03422666 Recruiting University Health Network, Toronto 2020-10-01
NCT03415568 Effects of MCDG Oil on Postprandial Lipid Metabolism https://ClinicalTrials.gov/show/NCT03415568 Completed Yonsei University 2017-07-28
NCT01267227 Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress https://ClinicalTrials.gov/show/NCT01267227 Completed University of Mississippi Medical Center 2012-02-29
NCT01256476 Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT01256476 Completed Kowa Research Institute, Inc. 2011-06-30
NCT01239004 Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy https://ClinicalTrials.gov/show/NCT01239004 Completed Radiant Research 2011-08-31
NCT01235832 The Effect of Avocado on Cardiovascular Disease (CVD) Risk Factors https://ClinicalTrials.gov/show/NCT01235832 Completed Penn State University 2012-12-31
NCT01236430 A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) https://ClinicalTrials.gov/show/NCT01236430 Completed Merck Sharp & Dohme Corp. 2011-11-30
NCT01228032 The Health Outcomes Management and Evaluation (HOME) Study https://ClinicalTrials.gov/show/NCT01228032 Completed Emory University 2015-07-31
NCT01220336 Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions https://ClinicalTrials.gov/show/NCT01220336 Completed University of California, San Francisco 2014-06-30
NCT01212159 Telephone Based Management of Hyperlipidemia https://ClinicalTrials.gov/show/NCT01212159 Completed Temple University 2015-07-31
NCT01152073 A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability) https://ClinicalTrials.gov/show/NCT01152073 Completed Healthy Drink Discoveries, Inc. 2010-09-30
NCT01146522 Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT01146522 Completed Novartis 2011-10-31
NCT01145742 Controlling Hypertension in Diabetes- Feasibility Study https://ClinicalTrials.gov/show/NCT01145742 Completed Albert Einstein College of Medicine 2009-09-30
NCT01142908 Cardiovascular Intervention Improvement Telemedicine Study https://ClinicalTrials.gov/show/NCT01142908 Completed VA Office of Research and Development 2015-04-30
NCT01133522 Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin https://ClinicalTrials.gov/show/NCT01133522 Completed Amgen 2011-09-14
NCT01131832 Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols https://ClinicalTrials.gov/show/NCT01131832 Completed University of Manitoba 2012-02-29
NCT01122394 Reducing Risk of Recurrence https://ClinicalTrials.gov/show/NCT01122394 Completed VA Office of Research and Development 2015-06-30
NCT01099176 Effects of Hypolipemic Treatment on Adipokines https://ClinicalTrials.gov/show/NCT01099176 Completed Medical University of Silesia 2009-05-31
NCT01089231 Effects of Omega-3 Fatty Acids on the Human Gene Expression https://ClinicalTrials.gov/show/NCT01089231 Completed Gottfried Wilhelm Leibniz Universität Hannover 2010-07-31
NCT01057654 A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin https://ClinicalTrials.gov/show/NCT01057654 Completed University Hospital, Bonn 1996-04-30
NCT01056549 Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans https://ClinicalTrials.gov/show/NCT01056549 Completed University Health Network, Toronto 2011-09-30
NCT01050465 MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use https://ClinicalTrials.gov/show/NCT01050465 Completed University of Missouri-Columbia 2010-10-31
NCT01047280 Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans https://ClinicalTrials.gov/show/NCT01047280 Completed University of Manitoba 2008-03-31
NCT01046968 Lepticore in Metabolic Syndrome and Weight Loss https://ClinicalTrials.gov/show/NCT01046968 Completed University of Yaounde 1 2009-11-30
NCT01026103 Tri Staple Technology Stapler Used in Gastric Bypass https://ClinicalTrials.gov/show/NCT01026103 Completed Medtronic - MITG 2011-03-31
NCT01023607 Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS) https://ClinicalTrials.gov/show/NCT01023607 Completed Harbin Medical University 2013-08-31
NCT01012219 A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) https://ClinicalTrials.gov/show/NCT01012219 Completed Merck Sharp & Dohme Corp. 2010-03-31
NCT00974272 Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation https://ClinicalTrials.gov/show/NCT00974272 Completed Carl T. Hayden VA Medical Center 2008-11-30
NCT00973115 Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00973115 Completed Hanmi Pharmaceutical Company Limited 2009-08-31
NCT00955903 Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults https://ClinicalTrials.gov/show/NCT00955903 Completed University of Alabama at Birmingham 2014-08-31
NCT00955227 Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels https://ClinicalTrials.gov/show/NCT00955227 Completed University of Manitoba 2011-05-31
NCT00941603 Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) https://ClinicalTrials.gov/show/NCT00941603 Completed Merck Sharp & Dohme Corp. 2010-02-22
NCT00938405 Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00938405 Completed University of Colorado Denver School of Medicine Barbara Davis Center 2009-12-31
NCT00917878 Postprandial Effects of Milk and Milk Constituents https://ClinicalTrials.gov/show/NCT00917878 Completed Maastricht University Medical Center 2009-07-31
NCT00910988 Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone https://ClinicalTrials.gov/show/NCT00910988 Completed Washington University School of Medicine 2012-06-30
NCT00897975 Red Yeast Rice and Phytosterols In Statin Intolerance https://ClinicalTrials.gov/show/NCT00897975 Completed Chestnut Hill Health System 2010-11-30
NCT00887653 Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy https://ClinicalTrials.gov/show/NCT00887653 Completed The Miriam Hospital 2012-06-30
NCT00877825 The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy https://ClinicalTrials.gov/show/NCT00877825 Completed University of Toronto NA
NCT00863564 Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects https://ClinicalTrials.gov/show/NCT00863564 Completed Aarhus University Hospital 2009-10-31
NCT00846300 A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas https://ClinicalTrials.gov/show/NCT00846300 Completed The University of Texas Health Science Center at San Antonio 2003-05-31
NCT02833844 Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia https://ClinicalTrials.gov/show/NCT02833844 Completed Amgen 2019-07-09
NCT00827307 Zoladex Plus Tamoxifen in Breast Cancer https://ClinicalTrials.gov/show/NCT00827307 Completed Zhejiang Cancer Hospital 2011-06-30
NCT03895580 Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction https://ClinicalTrials.gov/show/NCT03895580 Recruiting University of Cincinnati 2019-12-31
NCT00947635 Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention https://ClinicalTrials.gov/show/NCT00947635 Completed University of Alberta 2009-06-30
NCT00813527 Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels https://ClinicalTrials.gov/show/NCT00813527 Completed Takeda 2007-01-31
NCT00810979 Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00810979 Completed Kadmon Corporation, LLC 2009-09-30
NCT00809874 Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects https://ClinicalTrials.gov/show/NCT00809874 Completed Aarhus University Hospital 2008-12-31
NCT01984424 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 https://ClinicalTrials.gov/show/NCT01984424 Completed Amgen 2015-11-10
NCT01645046 The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT01645046 Completed Zhejiang University 2009-06-30
NCT03332641 Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol. https://ClinicalTrials.gov/show/NCT03332641 Completed Hanyang University 2017-09-28
NCT02278471 The SCCS Polypill Pilot Trial https://ClinicalTrials.gov/show/NCT02278471 Completed Vanderbilt University Medical Center 2018-06-27
NCT02100839 Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia https://ClinicalTrials.gov/show/NCT02100839 Completed LipimetiX Development, LLC 2014-11-30
NCT03961763 Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins https://ClinicalTrials.gov/show/NCT03961763 Completed University of Chester 2017-11-01
NCT03690778 The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. https://ClinicalTrials.gov/show/NCT03690778 Completed Jeil Pharmaceutical Co., Ltd. 2019-02-01
NCT00789295 Mediterranean Diet and Postprandial Lipemia https://ClinicalTrials.gov/show/NCT00789295 Completed Federico II University NA
NCT00787306 Cardiovascular Health And Risk Modification in Family Health Teams https://ClinicalTrials.gov/show/NCT00787306 Completed University of Toronto 2009-06-30
NCT00778804 Preventing Heart Disease in Underserved Patients https://ClinicalTrials.gov/show/NCT00778804 Completed Temple University 2007-02-28
NCT00758303 A Study to Evaluate the Lipid Regulating Effects of TRIA-662 https://ClinicalTrials.gov/show/NCT00758303 Completed Cortria Corporation 2008-12-31
NCT00756405 Effects of Dietary Antioxidants on Cardiovascular Risk Factors https://ClinicalTrials.gov/show/NCT00756405 Completed Stanford University 2008-12-31
NCT00754039 Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00754039 Completed Daiichi Sankyo, Inc. 2003-09-30
NCT00753883 Ezetrol Post-Marketing Study https://ClinicalTrials.gov/show/NCT00753883 Completed Merck Sharp & Dohme Corp. 2008-05-31
NCT00749801 Efficacy and Safety of Geneferm Nattokinase https://ClinicalTrials.gov/show/NCT00749801 Completed Chi Mei Medical Hospital 2008-03-31
NCT00713167 The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) https://ClinicalTrials.gov/show/NCT00713167 Completed Shahid Beheshti University of Medical Sciences 2008-12-31
NCT00707746 Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects https://ClinicalTrials.gov/show/NCT00707746 Completed Kastle Therapeutics, LLC 2010-08-31
NCT00701883 Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00701883 Completed CymaBay Therapeutics, Inc. 2008-08-31
NCT00699023 Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00699023 Completed Federico II University 2009-10-31
NCT00694109 An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00694109 Completed Kastle Therapeutics, LLC 2014-09-30
NCT00688896 Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia https://ClinicalTrials.gov/show/NCT00688896 Completed Akros Pharma Inc. 2003-04-30
NCT00686010 Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia https://ClinicalTrials.gov/show/NCT00686010 Completed Japan Tobacco Inc. 2001-01-31
NCT00685737 Safety of a Hypolipidemic Agent in Healthy Normal Volunteers https://ClinicalTrials.gov/show/NCT00685737 Completed Pharmena North America 2008-06-30
NCT00669500 Body Worlds 3 Nutrition Display https://ClinicalTrials.gov/show/NCT00669500 Completed Oregon Health and Science University 2008-03-31
NCT00668109 Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia https://ClinicalTrials.gov/show/NCT00668109 Completed Bayer 2004-06-30
NCT00660491 Endothelial Dysfunction Induced by Postprandial Lipemia https://ClinicalTrials.gov/show/NCT00660491 Completed Norwegian University of Science and Technology 2008-09-30
NCT00660075 Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00660075 Completed Laval University 2009-01-31
NCT00652431 Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) https://ClinicalTrials.gov/show/NCT00652431 Completed Merck Sharp & Dohme Corp. 2007-07-31
NCT00651560 Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) https://ClinicalTrials.gov/show/NCT00651560 Completed Merck Sharp & Dohme Corp. 2005-12-23
NCT00645424 A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol https://ClinicalTrials.gov/show/NCT00645424 Completed Pfizer NA
NCT00635544 Cross-Over Multicentre Study in Adolescents https://ClinicalTrials.gov/show/NCT00635544 Completed Federico II University 2008-01-31
NCT00634608 Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow https://ClinicalTrials.gov/show/NCT00634608 Completed University of Missouri-Columbia 2009-03-31
NCT00630734 Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin https://ClinicalTrials.gov/show/NCT00630734 Completed University of Colorado, Denver 2009-10-31
NCT00607373 Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00607373 Completed Kastle Therapeutics, LLC 2009-03-31
NCT00603876 Efficacy of Almonds Added to Chronic Statin Therapy https://ClinicalTrials.gov/show/NCT00603876 Completed University of Kansas Medical Center 2012-12-31
NCT00603590 Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease https://ClinicalTrials.gov/show/NCT00603590 Completed Tehran University of Medical Sciences 2008-06-30
NCT00593632 A Controlled Trial of High Dietary Fiber Intake on Serum Lipids https://ClinicalTrials.gov/show/NCT00593632 Completed The Cleveland Clinic 2011-07-31
NCT00569959 Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients https://ClinicalTrials.gov/show/NCT00569959 Completed HealthPartners Institute NA
NCT00566267 A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet https://ClinicalTrials.gov/show/NCT00566267 Completed Corporal Michael J. Crescenz VA Medical Center NA
NCT00565292 A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) https://ClinicalTrials.gov/show/NCT00565292 Completed Merck Sharp & Dohme Corp. 2006-08-31
NCT00559962 Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS https://ClinicalTrials.gov/show/NCT00559962 Completed Aegerion Pharmaceuticals, Inc. 2008-10-31
NCT00552747 Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease https://ClinicalTrials.gov/show/NCT00552747 Completed National Heart Institute, Mexico 2010-03-31
NCT00552097 Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) https://ClinicalTrials.gov/show/NCT00552097 Completed Merck Sharp & Dohme Corp. 2006-04-25
NCT00536510 Effect of MK0524A on Cholesterol Levels (0524A-048) https://ClinicalTrials.gov/show/NCT00536510 Completed Merck Sharp & Dohme Corp. 2008-03-31
NCT00516594 The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption https://ClinicalTrials.gov/show/NCT00516594 Completed University of Toronto NA
NCT00507520 Almond Dose Response Study. https://ClinicalTrials.gov/show/NCT00507520 Completed University of Toronto NA
NCT00490672 Community Based Multiple Risk Factors Intervention Strategy https://ClinicalTrials.gov/show/NCT00490672 Completed Ministry of Health, Malaysia 2008-12-31
NCT00484419 Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn’t Completely Controlled With Metformin https://ClinicalTrials.gov/show/NCT00484419 Completed Daiichi Sankyo, Inc. 2008-04-30
NCT00477594 Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00477594 Completed Kastle Therapeutics, LLC 2011-03-31
NCT00473655 Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients https://ClinicalTrials.gov/show/NCT00473655 Completed AstraZeneca 2009-02-28
NCT00469365 Pharmacy Interventions to Improve Chronic Disease Medication Refill https://ClinicalTrials.gov/show/NCT00469365 Completed Medical University of South Carolina NA
NCT00465751 Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism https://ClinicalTrials.gov/show/NCT00465751 Completed University Hospital, Basel, Switzerland NA
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) https://ClinicalTrials.gov/show/NCT00465088 Completed Abbott 2008-02-29
NCT00459745 A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia https://ClinicalTrials.gov/show/NCT00459745 Completed Shionogi Inc. 2008-04-30
NCT00457262 Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women https://ClinicalTrials.gov/show/NCT00457262 Completed Iran University of Medical Sciences NA
NCT00451828 Cholesterol and Pharmacogenetic Study https://ClinicalTrials.gov/show/NCT00451828 Completed UCSF Benioff Children’s Hospital Oakland 2004-10-31
NCT00438893 Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet https://ClinicalTrials.gov/show/NCT00438893 Completed University of Toronto 2009-05-31
NCT00438425 Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia https://ClinicalTrials.gov/show/NCT00438425 Completed University of Toronto 2009-09-30
NCT00430430 Lipoprotein Turnover on Low- and High-MUFA Portfolio Diets https://ClinicalTrials.gov/show/NCT00430430 Completed University of Toronto 2009-04-30
NCT00414986 Using Learning Teams for Reflective Adaptation for Diabetes and Depression https://ClinicalTrials.gov/show/NCT00414986 Completed University of Colorado, Denver 2012-02-29
NCT00405769 Lipid Lowering in Patients With Statin Intolerance https://ClinicalTrials.gov/show/NCT00405769 Completed Chestnut Hill Health System NA
NCT00393419 Federal Study of Adherence to Medications in the Elderly (FAME) https://ClinicalTrials.gov/show/NCT00393419 Completed Walter Reed Army Medical Center NA
NCT00386971 Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART https://ClinicalTrials.gov/show/NCT00386971 Completed University of California, Davis 2009-12-31
NCT00378833 Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) https://ClinicalTrials.gov/show/NCT00378833 Completed Merck Sharp & Dohme Corp. 2007-03-31
NCT00376584 Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) https://ClinicalTrials.gov/show/NCT00376584 Completed Merck Sharp & Dohme Corp. 2007-01-31
NCT00819975 Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00819975 Completed Aarhus University Hospital NA
NCT00365742 Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements https://ClinicalTrials.gov/show/NCT00365742 Completed Chestnut Hill Health System NA
NCT00362934 Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin https://ClinicalTrials.gov/show/NCT00362934 Completed Solvay Pharmaceuticals 2008-08-31
NCT00362206 Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin https://ClinicalTrials.gov/show/NCT00362206 Completed Solvay Pharmaceuticals 2008-09-30
NCT00362180 Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration https://ClinicalTrials.gov/show/NCT00362180 Completed Kastle Therapeutics, LLC 2010-03-31
NCT00360217 The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes https://ClinicalTrials.gov/show/NCT00360217 Completed Maine Center for Lipids and Cardiovascular Health NA
NCT00360074 Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation https://ClinicalTrials.gov/show/NCT00360074 Completed University Hospital Freiburg NA
NCT00349375 Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy https://ClinicalTrials.gov/show/NCT00349375 Completed Solvay Pharmaceuticals 2008-09-30
NCT00349284 A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome https://ClinicalTrials.gov/show/NCT00349284 Completed Solvay Pharmaceuticals NA
NCT00345722 The Effect of Strawberries in a Cholesterol-Lowering Dietary Portfolio https://ClinicalTrials.gov/show/NCT00345722 Completed University of Toronto NA
NCT00345657 Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care https://ClinicalTrials.gov/show/NCT00345657 Completed In His Image NA
NCT00328523 TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) https://ClinicalTrials.gov/show/NCT00328523 Completed Merck Sharp & Dohme Corp. 2006-01-31
NCT00308386 DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change) https://ClinicalTrials.gov/show/NCT00308386 Completed Milton S. Hershey Medical Center 2011-07-27
NCT00296400 Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease https://ClinicalTrials.gov/show/NCT00296400 Completed AstraZeneca 2009-06-30
NCT00289900 Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) https://ClinicalTrials.gov/show/NCT00289900 Completed Merck Sharp & Dohme Corp. 2010-08-06
NCT00275145 Effects of Resistance and Aerobic Exercise on Cardiovascular Health https://ClinicalTrials.gov/show/NCT00275145 Completed Duke University 2008-12-31
NCT00272402 Reducing Clinical Inertia in Diabetes Care https://ClinicalTrials.gov/show/NCT00272402 Completed HealthPartners Institute 2008-06-30
NCT00271817 To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) https://ClinicalTrials.gov/show/NCT00271817 Completed Merck Sharp & Dohme Corp. 2008-02-29
NCT00269217 Lipid Efficacy Study (0524B-022)(COMPLETED) https://ClinicalTrials.gov/show/NCT00269217 Completed Merck Sharp & Dohme Corp. 2007-01-31
NCT00269204 Lipid Efficacy/Tolerability Study (0524A-020) https://ClinicalTrials.gov/show/NCT00269204 Completed Merck Sharp & Dohme Corp. 2006-12-31
NCT00267254 A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. https://ClinicalTrials.gov/show/NCT00267254 Completed Pfizer NA
NCT00255216 Policosanol for the Treatment of Hypercholesterolemia https://ClinicalTrials.gov/show/NCT00255216 Completed Atrium Health NA
NCT00249938 Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. https://ClinicalTrials.gov/show/NCT00249938 Completed University of Colorado, Denver NA
NCT00246402 Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV https://ClinicalTrials.gov/show/NCT00246402 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00246376 Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia https://ClinicalTrials.gov/show/NCT00246376 Completed Baylor College of Medicine 2009-09-30
NCT00244231 Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia https://ClinicalTrials.gov/show/NCT00244231 Completed Genovate Biotechnology Co., Ltd., NA
NCT00236210 A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program https://ClinicalTrials.gov/show/NCT00236210 Completed Group Health Centre 2006-07-31
NCT00227500 Pravastatin for Hyperlipidaemia in HIV. https://ClinicalTrials.gov/show/NCT00227500 Completed Kirby Institute NA
NCT00225628 Improving Quality With Outpatient Decision Support https://ClinicalTrials.gov/show/NCT00225628 Completed Agency for Healthcare Research and Quality (AHRQ) NA
NCT00225017 Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study https://ClinicalTrials.gov/show/NCT00225017 Completed Northwestern University 2008-06-30
NCT00222833 The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia https://ClinicalTrials.gov/show/NCT00222833 Completed University of Pittsburgh 2005-12-31
NCT00214604 Type III Dysbetalipoproteinemia https://ClinicalTrials.gov/show/NCT00214604 Completed AstraZeneca 2007-02-28
NCT00211705 Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study) https://ClinicalTrials.gov/show/NCT00211705 Completed Mitsukoshi Health and Welfare Foundation NA
NCT00203476 A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction https://ClinicalTrials.gov/show/NCT00203476 Completed Tuscaloosa Research & Education Advancement Corporation 2008-01-31
NCT00202241 The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS https://ClinicalTrials.gov/show/NCT00202241 Completed Queen’s University NA
NCT00200993 Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) https://ClinicalTrials.gov/show/NCT00200993 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-04-30
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin https://ClinicalTrials.gov/show/NCT00195793 Completed Abbott NA
NCT00194428 Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons https://ClinicalTrials.gov/show/NCT00194428 Completed Temple University 2007-10-31
NCT00189085 Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function https://ClinicalTrials.gov/show/NCT00189085 Completed UMC Utrecht NA
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients https://ClinicalTrials.gov/show/NCT00184951 Completed Radboud University 2005-07-31
NCT00175084 Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers https://ClinicalTrials.gov/show/NCT00175084 Completed Tufts University 2007-06-30
NCT00175071 Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers https://ClinicalTrials.gov/show/NCT00175071 Completed Tufts University 2007-04-30
NCT00174330 Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia https://ClinicalTrials.gov/show/NCT00174330 Completed Pfizer NA
NCT00174304 Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. https://ClinicalTrials.gov/show/NCT00174304 Completed Pfizer NA
NCT00172419 The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. https://ClinicalTrials.gov/show/NCT00172419 Completed National Taiwan University Hospital 2008-12-31
NCT00160329 Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00160329 Completed Stanford University 2007-04-30
NCT00157638 Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics https://ClinicalTrials.gov/show/NCT00157638 Completed McMaster University NA
NCT00147251 Stop Atherosclerosis in Native Diabetics Study https://ClinicalTrials.gov/show/NCT00147251 Completed Medstar Health Research Institute NA
NCT00143234 Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels https://ClinicalTrials.gov/show/NCT00143234 Completed Pfizer NA
NCT00139061 Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate https://ClinicalTrials.gov/show/NCT00139061 Completed Pfizer NA
NCT00138762 A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol https://ClinicalTrials.gov/show/NCT00138762 Completed Pfizer 2006-08-31
NCT00137462 Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. https://ClinicalTrials.gov/show/NCT00137462 Completed Pfizer NA
NCT00136981 Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. https://ClinicalTrials.gov/show/NCT00136981 Completed Pfizer NA
NCT00136942 A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol https://ClinicalTrials.gov/show/NCT00136942 Completed Pfizer NA
NCT00134498 A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides https://ClinicalTrials.gov/show/NCT00134498 Completed Pfizer NA
NCT00134485 Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia https://ClinicalTrials.gov/show/NCT00134485 Completed Pfizer NA
NCT00134173 A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease https://ClinicalTrials.gov/show/NCT00134173 Completed Pfizer NA
NCT00127751 Heart Disease on the Mend https://ClinicalTrials.gov/show/NCT00127751 Completed Stanford University NA
NCT00123435 Veterans Walk for Health Study https://ClinicalTrials.gov/show/NCT00123435 Completed VA Office of Research and Development 2007-11-30
NCT00117494 Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) https://ClinicalTrials.gov/show/NCT00117494 Completed French National Agency for Research on AIDS and Viral Hepatitis 2007-03-31
NCT00114855 The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose https://ClinicalTrials.gov/show/NCT00114855 Completed Oslo University Hospital 2005-12-31
NCT00109603 Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy https://ClinicalTrials.gov/show/NCT00109603 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-07-31
NCT00108459 Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes https://ClinicalTrials.gov/show/NCT00108459 Completed VA Office of Research and Development NA
NCT00093899 A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) https://ClinicalTrials.gov/show/NCT00093899 Completed Merck Sharp & Dohme Corp. 2005-09-30
NCT00092573 Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) https://ClinicalTrials.gov/show/NCT00092573 Completed Merck Sharp & Dohme Corp. 2004-11-30
NCT00092560 Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) https://ClinicalTrials.gov/show/NCT00092560 Completed Merck Sharp & Dohme Corp. 2003-12-31
NCT00090402 Fish Oil and Alpha Lipoic Acid in Treating Alzheimer’s Disease https://ClinicalTrials.gov/show/NCT00090402 Completed Oregon Health and Science University 2006-01-03
NCT00072891 Improving Medication Adherence in Comorbid Conditions https://ClinicalTrials.gov/show/NCT00072891 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00059254 Differential Metabolism of Dietary Fatty Acids https://ClinicalTrials.gov/show/NCT00059254 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2005-04-30
NCT00002417 A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications https://ClinicalTrials.gov/show/NCT00002417 Completed NIH AIDS Clinical Trials Information Service NA
NCT00817973 Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein https://ClinicalTrials.gov/show/NCT00817973 Completed Aarhus University Hospital NA
NCT00106236 Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction https://ClinicalTrials.gov/show/NCT00106236 Completed Sapporo Health Promotion Foundation NA
NCT00069524 Antihyperlipidemic Effects of Oyster Mushrooms https://ClinicalTrials.gov/show/NCT00069524 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00006493 Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia https://ClinicalTrials.gov/show/NCT00006493 Completed National Center for Research Resources (NCRR) NA
NCT00000538 Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA) https://ClinicalTrials.gov/show/NCT00000538 Completed University of North Carolina, Chapel Hill 1995-05-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03225157 Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation https://ClinicalTrials.gov/show/NCT03225157 Completed National Institutes of Health Clinical Center (CC) 2020-02-28
NCT02952638 Dietary Sources of Lysophospholipids https://ClinicalTrials.gov/show/NCT02952638 Recruiting University of Kentucky 2020-06-30
NCT02933138 Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia https://ClinicalTrials.gov/show/NCT02933138 Completed Hospices Civils de Lyon 2012-07-31
NCT02826720 Is There a Relationship Between Hyperlipidemia and Periodontitis? https://ClinicalTrials.gov/show/NCT02826720 Completed Marmara University 2016-01-31
NCT02808130 PERIODONTAL DISEASE AND HYPERLIPIDEMIA https://ClinicalTrials.gov/show/NCT02808130 Completed Ondokuz Mayıs University 2014-08-31
NCT02791802 Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes https://ClinicalTrials.gov/show/NCT02791802 Recruiting Technische Universität Dresden 2020-06-30
NCT02770131 Chart Review of Repatha® in Subjects With Hyperlipidaemia https://ClinicalTrials.gov/show/NCT02770131 Recruiting Amgen 2021-06-24
NCT02730390 Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance https://ClinicalTrials.gov/show/NCT02730390 Completed Otsuka Pharmaceutical, Inc., Philippines 2013-07-31
NCT02285166 Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3 https://ClinicalTrials.gov/show/NCT02285166 Completed Takeda 2020-03-31
NCT00001154 Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins https://ClinicalTrials.gov/show/NCT00001154 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02402803 Dried Blood Spot- Statin Pilot Study https://ClinicalTrials.gov/show/NCT02402803 Recruiting Cedars-Sinai Medical Center 2019-10-31
NCT02388633 Acute Microvascular Changes With LDL Apheresis https://ClinicalTrials.gov/show/NCT02388633 Completed Oregon Health and Science University 2018-07-01
NCT02163044 The Hellenic Postprandial Lipemia Study (HPLS) https://ClinicalTrials.gov/show/NCT02163044 Completed Hellenic College of Treatment of Atherosclerosis 2019-08-31
NCT02153073 Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters https://ClinicalTrials.gov/show/NCT02153073 Completed Takeda 2017-05-31
NCT01798030 Vitamin D Retrospective Study and Role With Disease https://ClinicalTrials.gov/show/NCT01798030 Active, not recruiting Baltimore VA Medical Center 2020-11-30
NCT01786421 Diurnal Triglyceridemia in Relation to Alcohol Intake https://ClinicalTrials.gov/show/NCT01786421 Completed Sint Franciscus Gasthuis 2005-12-31
NCT01753232 Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter https://ClinicalTrials.gov/show/NCT01753232 Completed Fresenius Medical Care Deutschland GmbH 2014-12-31
NCT01592084 Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis https://ClinicalTrials.gov/show/NCT01592084 Completed The Methodist Hospital System 2011-09-30
NCT01569867 Genetic Influence on Statin Pharmacokinetics https://ClinicalTrials.gov/show/NCT01569867 Recruiting Ohio State University 2020-06-30
NCT01393249 PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL https://ClinicalTrials.gov/show/NCT01393249 Completed Rigshospitalet, Denmark 2013-12-31
NCT04330209 Comparing a Low-GI Nutrigenetic and Ketogenic Diet for Weight Loss With 18 Month Follow-up https://ClinicalTrials.gov/show/NCT04330209 Completed Iuliu Hatieganu University of Medicine and Pharmacy 2016-12-31
NCT01033513 SOS Nutrition Project https://ClinicalTrials.gov/show/NCT01033513 Completed University of North Carolina, Charlotte NA
NCT00891124 Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). https://ClinicalTrials.gov/show/NCT00891124 Completed AstraZeneca NA
NCT00882336 European Study of Cardiovascular Risk https://ClinicalTrials.gov/show/NCT00882336 Completed AstraZeneca NA
NCT00828945 Compliance With Treatment For Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00828945 Completed Pfizer 2011-03-31
NCT00823277 Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight https://ClinicalTrials.gov/show/NCT00823277 Completed Zealand University Hospital 2012-08-31
NCT03329729 PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT https://ClinicalTrials.gov/show/NCT03329729 Completed Elpen Pharmaceutical Co. Inc. 2019-01-30
NCT04094194 Meta-analysis of the Nordic Dietary Pattern on Cardiometabolic Risk and Cardiovascular Outcomes https://ClinicalTrials.gov/show/NCT04094194 Active, not recruiting University of Toronto 2019-12-01
NCT00726362 To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia https://ClinicalTrials.gov/show/NCT00726362 Completed AstraZeneca 2009-11-30
NCT00723723 Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) https://ClinicalTrials.gov/show/NCT00723723 Completed Merck Sharp & Dohme Corp. 2009-06-30
NCT00701454 Survey of Thai-Muslim Health Status https://ClinicalTrials.gov/show/NCT00701454 Completed Mahidol University 2006-04-30
NCT00654459 Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function https://ClinicalTrials.gov/show/NCT00654459 Completed Federico II University 2008-01-31
NCT00628524 Homburg Cream & Sugar Study https://ClinicalTrials.gov/show/NCT00628524 Completed University Hospital, Saarland 2013-07-31
NCT00536965 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets https://ClinicalTrials.gov/show/NCT00536965 Completed AstraZeneca 2007-12-31
NCT00536796 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets https://ClinicalTrials.gov/show/NCT00536796 Completed AstraZeneca 2007-12-31
NCT00534105 Lipid Metabolism in Gestational Diabetes https://ClinicalTrials.gov/show/NCT00534105 Completed Baystate Medical Center 2010-11-30
NCT00516204 Diabetic Under 70 (Diabetics Below 70) https://ClinicalTrials.gov/show/NCT00516204 Completed AstraZeneca 2007-12-31
NCT00481299 Insulin Resistance in Women With Prolactinoma https://ClinicalTrials.gov/show/NCT00481299 Completed Universidade Federal do Rio de Janeiro NA
NCT00451464 Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients https://ClinicalTrials.gov/show/NCT00451464 Completed National Taiwan University Hospital NA
NCT00382564 Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease https://ClinicalTrials.gov/show/NCT00382564 Completed National Institutes of Health Clinical Center (CC) NA
NCT00381992 Risk Assessment of Long-Haul Truck Drivers https://ClinicalTrials.gov/show/NCT00381992 Completed Wake Forest University Health Sciences 2010-03-31
NCT00365235 Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals https://ClinicalTrials.gov/show/NCT00365235 Completed University of California, Los Angeles 2011-06-30
NCT00001142 Metabolism and Body Shape of Healthy Children and Children With Chronic Infections https://ClinicalTrials.gov/show/NCT00001142 Completed National Institutes of Health Clinical Center (CC) NA
NCT00781560 Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal https://ClinicalTrials.gov/show/NCT00781560 Completed AstraZeneca NA
NCT00005368 Genetic Epidemiology of Hypertriglyceridemia https://ClinicalTrials.gov/show/NCT00005368 Completed University of Washington NA
NCT00005313 Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia https://ClinicalTrials.gov/show/NCT00005313 Completed University of Washington 2003-03-31
NCT00005128 Lipid Research Clinics Population Studies https://ClinicalTrials.gov/show/NCT00005128 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001226 Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins https://ClinicalTrials.gov/show/NCT00001226 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04457024 Tennis Elbow Patients Undergoing Closed Therapy Can Easily Cause Tendon Tear https://ClinicalTrials.gov/show/NCT04457024 Completed Peking University Third Hospital 2020-02-20
NCT03293810 Glybera Registry, Lipoprotein Lipase Deficient (LPLD) Patients https://ClinicalTrials.gov/show/NCT03293810 Active, not recruiting UniQure Biopharma B.V. 2033-09-30
NCT03065543 Hyperlipidemia Therapy TERCET Zabrze Registry https://ClinicalTrials.gov/show/NCT03065543 Recruiting Silesian Centre for Heart Diseases 2016-12-31
NCT02341664 Patient and Provider Assessment of Lipid Management Registry https://ClinicalTrials.gov/show/NCT02341664 Completed Duke University 2016-02-29
NCT03862183 Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study https://ClinicalTrials.gov/show/NCT03862183 Recruiting Huashan Hospital 2020-12-30